| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.39B | 88.67B | 80.92B | 64.51B | 51.09B | 46.77B |
| Gross Profit | 11.70B | 13.28B | 10.11B | 8.64B | 7.26B | 6.04B |
| EBITDA | 9.04B | 9.67B | 9.07B | 6.60B | 6.39B | 4.98B |
| Net Income | 3.99B | 5.50B | 3.09B | 2.49B | 2.15B | 1.83B |
Balance Sheet | ||||||
| Total Assets | 167.64B | 177.61B | 167.04B | 155.91B | 126.19B | 123.42B |
| Cash, Cash Equivalents and Short-Term Investments | 6.06B | 8.03B | 4.98B | 6.35B | 8.42B | 7.46B |
| Total Debt | 76.75B | 80.48B | 77.16B | 70.56B | 54.36B | 56.52B |
| Total Liabilities | 108.33B | 114.07B | 108.66B | 99.85B | 78.31B | 77.86B |
| Stockholders Equity | 59.31B | 63.53B | 58.38B | 51.81B | 44.61B | 42.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.51B | -4.90B | -8.70B | 5.06B | -5.75B |
| Operating Cash Flow | 0.00 | 8.15B | 5.80B | 3.68B | 6.98B | 4.24B |
| Investing Cash Flow | 0.00 | -3.33B | -10.03B | -16.97B | -3.05B | -9.72B |
| Financing Cash Flow | 0.00 | -1.83B | 2.86B | 11.22B | -2.97B | -3.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ¥21.02B | 6.04 | ― | 1.29% | 1.42% | 88.77% | |
64 Neutral | ¥9.76B | 2.10 | ― | 4.99% | 9.16% | 146.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥45.24B | 8.46 | ― | 2.84% | 9.58% | 70.39% | |
57 Neutral | ¥16.28B | 20.95 | ― | 1.38% | 8.18% | 40.68% | |
50 Neutral | ¥6.58B | -36.82 | ― | 0.30% | -2.80% | 3.74% | |
47 Neutral | ¥10.29B | 38.42 | ― | 5.77% | 2.31% | -91.89% |